Voltage-gated potassium channels regulate the response of retinal growth cones to axon extension and guidance cues.
Xenopus retinal ganglion cell growth cones express various voltage-gated potassium (Kv) channels. We showed previously that 4-aminopyridine and tetraethylammonium have different effects on the outward currents of embryonic Xenopus retinal ganglion cells. Therefore, we asked whether these Kv channel inhibitors differentially regulate the response of retinal ganglion cell growth cones to extrinsic cues. First, we tested the role of Kv channels in axon extension mediated by a substrate bound cue and found that 4-aminopyridine blocked, whereas tetraethylammonium enhanced basal extension on laminin. Yet, when the growth cones were stimulated to extend with application of soluble growth factors, both inhibitors resulted in a return to the basal extension rates observed in the presence of laminin alone. Second, we asked if Kv channels modulate the response of retinal ganglion cell growth cones to a guidance cue, the chemorepellent fibroblast growth factor-2. When presented in a gradient to one side of the growth cone, fibroblast growth factor-2 repulsed retinal ganglion cell growth cones in the presence of 4-aminopyridine but not tetraethylammonium. These data argue that tetraethylammonium- and 4-aminopyridine-sensitive Kv channels differ in the manner by which they regulate the response of retinal ganglion cell axons to extension and guidance cues. Non-ratiometric calcium imaging indicated that differences in the ability of tetraethylammonium- and 4-aminopyridine-sensitive Kv channels to regulate calcium activity within the growth cone may underlie their unique modulation of growth cone behaviour.
Pollock
N S
NS
Genes and Development Research Group, University of Calgary, Alberta, Canada.
Atkinson-Leadbeater
K
K
Johnston
J
J
Larouche
M
M
Wildering
W C
WC
McFarlane
S
S
D015761:4-Aminopyridine / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D003463:Cues; D003952:Diagnostic Imaging / Q000379:methods; D004347:Drug Interactions; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D020439:Growth Cones / Q000187:drug effects / Q000502:physiology*; D018715:Microscopy, Video / Q000379:methods; D016501:Neurites / Q000187:drug effects / Q000502:physiology; D009924:Organ Culture Techniques; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024642:Potassium Channels, Voltage-Gated / Q000502:physiology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D012160:Retina / Q000166:cytology; D012165:Retinal Ganglion Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology; D013997:Time Factors; D014982:Xenopus laevis
D026902:Potassium Channel Blockers; D024642:Potassium Channels, Voltage-Gated; D000644:Quaternary Ammonium Compounds; D016222:Fibroblast Growth Factor 2; D015761:4-Aminopyridine; C027917:tetramethylammonium; D002118:Calcium